Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

Clinical trial NCT06042257 · TERMINATED

Trial details

NCT number: NCT06042257
Sponsor: Rachel G. Greenberg, MD, MB, MHS
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperactivity in Children With Down Syndrome Impulsivity in Children With Down Syndrome

Start date: 2024-12-09
Primary completion: 2025-05-17
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.